VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

iwCLL 2017 | How can we overcome ibrutinib resistance?

Meixiao Long, MD from the Ohio State University, Columbus, OH discusses leukemia cell resistance to ibrutinib. He believes in a multimodal combination approach with immunotherapy to bypass ibrutinib resistance, for e.g. tumour vaccines or checkpoint blockade, which can hopefully lead to durable response rates. This interview was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 held in New York, NY.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter